International
GSK, UK DEMENTIA Research Institute (UK DRI) and Health Data Research UK (HDR UK).

The first ITS-KIND Study11, which aims to deepen the understanding of the new collaboration target UKS Health Data Ecosystem, will assess the potential link between the shingles vaccine and the dementia risk reduction, and the evidence of evidence increases in observations and retrospective health. Bluefoot and D of research can be strengthened.
GSK PLC (LSE/NYSE: GSK) announced today's major new research cooperation with UK DEMENTIA Research Institute (UK DRI) and Health Data Research UK (HDR UK).
The innovative project aims to explore the potential link between GSK's shingles vaccine, recombinant journey vaccine (RZV) and dementia risk using UKS Health Data Ecosystem. Success can act as a blueprint for the population -level health data research model and strengthen the UKS location as a major destination for scientific research.
More than 55 million people around the world have Dementia5, and the case is the world's population. It is difficult to identify potential opportunities to reduce the risk of dementia, but it is difficult to consider various complex factors that can contribute to the development of the disease.
Data in multiple lateral observation studies shows the potential link between 1, 2, 3, and 4 dementia risks, including RZV. However, after these studies, the fragrance and observation characteristics of these studies means that it is vulnerable to unmeasured confusion factors, and it is impossible to determine causal relationships.
The new research cooperation aims to overcome this by evaluating the impact of RZV vaccination on the decrease in dementia by using electronic health data of UKS National Health Service (NHS). UK7 is about 1.4 million and 66 years old, and the eligible electronic health records are expected to provide powerful and comprehensive data sets that describe factors such as RZV vaccination, age, gender and coexistence. The study will take four years to complete.
Tony Wood, the chief scientific director of GSK, said: Uks National Scale Health Data Resources offers important opportunities for cutting -edge research. We hope that this world -class research cooperation will not only answer major questions that will help reduce the risk of dementia, but also lead to data -led research to solve the root cause of complicated diseases.
Peter Kyle said: Dementia is one of the biggest challenges for the health of our time, and research is very important to impress a lot of life and face deadly effects. This is an excellent example of the private sector to cooperate with the public and third sectors to enhance the understanding of how to reduce the risk of dementia by utilizing the power of health data.
Professor Andrew Morris, the British Health Data Research Research Officer: Dementia, is represented by one of the greatest challenges of our time, which affects millions of families across the UK. We work closely with NHS in four UK countries to ensure data privacy and security to enable preventive research, deepening understanding of disease, and to support people to keep people healthier to help them live longer in treating illness.
Professor SIDDHARTHAN CHANDRAN, director of Dementia Research Institute, said: I hope to identify.
About EPI-ZOSTER-11
EPI-ZOSTER-11 is an analysis of the semi- and practical evidence of 65 and 66 years old when the UK Shingles National Immunization Program (NIP) is expanded on September 1, 20238.
Adults who turned 65 from that day were eligible to receive GSKS recombinant journey vaccines (RZV). As part of a step -by -step implementation plan, an adult at the age of 66 will be able to get vaccination at the age of 70 at the time of expansion. This can cause natural random assignments and allow for comprehensive comparison of dementia risks due to RZV vaccination, which can occupy factors such as age, gender and other medical conditions.
This data is collected from the DEYDITIED ELECTRONIC HELLTH Records (EHR), which consists of information on several connected health data sets, including primary care, secondary treatment, drug records and death records of the UK, Scotland, Wales and North Ireland. This data provides information on health results for all ages, ethnic, geographic locations, socioeconomic and personal characteristics. After the feasibility assessment, the EHR is 70 years old and is safely analyzed for about four years until the RZV is given.
DEYDITIED HELLTH DATA is held by National Health Services and can only be accessible through reliable and safe research environments that comply with data personal information and security regulations. Research data is not accessible to the purpose of GSK or out of the scope of this study.
The use of RZV in this research population is followed by the British product label and NIP.
Aboutrecombinant Zoster Vaccine
Recombinant Jostor Vaccine (or RZV) is a recombinant sub unit vaccine of non -live, represented by shingles prevention of adults over 50 years old. It can be combined with antigen, sugar protein E and AD01b and auxiliary system, and can help to overcome the natural age -related reduction of reactions to immunity that contributes to protecting adults over 50 years of age. In several countries, RZV has been approved for an increase in the risk of shingles for adults aged 18 or older. The use of RZV should be followed by official recommendations and local product labels.
See the product information for important doses, management and safety information provided in this link: https://www.ema.europa.eu/en/edicines/human/epar/shingrix.
About GSK
GSK is a global bio pharmaceutical company that integrates science, technology and talents to lead the disease together. Check out the details on gsk.com.
Health Data Research
Health Data Research UK is the National Institute of Health Data Science, which accelerates reliable use of reliable use of health data to enable people to improve people's lives. It is a charity organization that supports funds by the UK's research and innovation, the Ministry of Health and Social Welfare in the UK and the equal medical research charity of the equal medical research of North Ireland, Wales and Scotland. Learn more at https://www.hdruk.ac.uk/.
British Dementia Research Institute Information
UK Dementia Research Institute (UK DRI) is a world -renowned research institute that supports funds by the Medical Research Committee. The British DRI is dedicated to changing the results of people at risk of neurochromatic conditions, accelerating the discovery, development and delivery of interventions that help diagnose, treatment and ultimately prevent dementia. www.ukdri.ac.uk
Statement to the future prediction statement
GSK warns that the future prediction statements or predictions written by GSK, including the contents written by investors in this presentation, require the actual results to receive different risks and uncertainty. These factors include the factors described in item 3, but are not limited to it. The risk factors for the GSKS annual report for the 2024 form 20-F are included.
Reference Schwab P, et al. Reduction of risks of recombinant ancestors and dementia: Matched cohort studies using large -scale electronic health records and machine learning methodologies. Green released at the International Conference (AAIC) of the Alzheimer's Association; July 28, 2024, 2024, Philadelphia, Pa Taquet, M., Dercon, Q., TODD, JA et al. Shingles vaccines to be recombinant are related to the low risk of dementia. Nat Med 30, 27772781 (2024). https://doi.org/10.1038/s41591-024-03201-5 Eyting, M., et al. The causal evidence to prevent shingles prevents the proportion of dementia cases. Medrxiv: Free Print Server for Health Science. 2023 schnier, C., et al. Varicella zoster vaccine in Wales 2013-2020 decreases the incidence of dementia. Alzheimer's and dementia. 2022; 8 (1): E12293. WHO, 2023. Date approached in March 2025: https://www.who.int/news-room/Fact-heets/detail/dementia Zhang xx, tian Y Alzheimer's Disease Fertilized Risk Factors and Epidemiology of Prevention. J previous Alzheimer Dis. 2021; 8 (3): 313-321. Doi: 10.14283/jpad.2021.15. PMID: 34101789. The National Statistical Office (2023), the death toll registered in the UK and Wales: 2023. 2025 Approached in January 2025: https://www.ons.gov.uk/peOPEOPEOPOPOPULATIONAND AndCommunity/Birthsdeatsandmarreades/DeathErcone, 25323 UK LEGEPLACTS/2023. November 2024. Shingles Immunization Program: Information for medical practitioners. March 2025 Approach Date: Shingles Immunization Program: Information for Medical practitioners -GOV.UK CUNNINGAM, AL, etc. New England Journal. 2016; 375 (11): 1019-32. GSK exclusive AS01 auxiliary system is agenus Inc. (NASDAQ: Agen), MPL, and Liposomes include QS-21 stimuli supplements with licenses from the antigenic LLC, a subsidiary of the LLC. Coalesce -HDR UK
Sources 2/ https://www.gsk.com/en-gb/media/press-releases/gsk-uk-dementia-research-institute-uk-dri-and-health-data-research-uk-hdr-uk-to-collaborate-on-first-of-its-kind-dementia-research-initiative/ The mention sources can contact us to remove/changing this article |
What Are The Main Benefits Of Comparing Car Insurance Quotes Online
LOS ANGELES, CA / ACCESSWIRE / June 24, 2020, / Compare-autoinsurance.Org has launched a new blog post that presents the main benefits of comparing multiple car insurance quotes. For more info and free online quotes, please visit https://compare-autoinsurance.Org/the-advantages-of-comparing-prices-with-car-insurance-quotes-online/ The modern society has numerous technological advantages. One important advantage is the speed at which information is sent and received. With the help of the internet, the shopping habits of many persons have drastically changed. The car insurance industry hasn't remained untouched by these changes. On the internet, drivers can compare insurance prices and find out which sellers have the best offers. View photos The advantages of comparing online car insurance quotes are the following: Online quotes can be obtained from anywhere and at any time. Unlike physical insurance agencies, websites don't have a specific schedule and they are available at any time. Drivers that have busy working schedules, can compare quotes from anywhere and at any time, even at midnight. Multiple choices. Almost all insurance providers, no matter if they are well-known brands or just local insurers, have an online presence. Online quotes will allow policyholders the chance to discover multiple insurance companies and check their prices. Drivers are no longer required to get quotes from just a few known insurance companies. Also, local and regional insurers can provide lower insurance rates for the same services. Accurate insurance estimates. Online quotes can only be accurate if the customers provide accurate and real info about their car models and driving history. Lying about past driving incidents can make the price estimates to be lower, but when dealing with an insurance company lying to them is useless. Usually, insurance companies will do research about a potential customer before granting him coverage. Online quotes can be sorted easily. Although drivers are recommended to not choose a policy just based on its price, drivers can easily sort quotes by insurance price. Using brokerage websites will allow drivers to get quotes from multiple insurers, thus making the comparison faster and easier. For additional info, money-saving tips, and free car insurance quotes, visit https://compare-autoinsurance.Org/ Compare-autoinsurance.Org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc. "Online quotes can easily help drivers obtain better car insurance deals. All they have to do is to complete an online form with accurate and real info, then compare prices", said Russell Rabichev, Marketing Director of Internet Marketing Company. CONTACT: Company Name: Internet Marketing CompanyPerson for contact Name: Gurgu CPhone Number: (818) 359-3898Email: cgurgu@internetmarketingcompany.BizWebsite: https://compare-autoinsurance.Org/ SOURCE: Compare-autoinsurance.Org View source version on accesswire.Com:https://www.Accesswire.Com/595055/What-Are-The-Main-Benefits-Of-Comparing-Car-Insurance-Quotes-Online View photos
to request, modification Contact us at Here or collaboration@support.exbulletin.com